Sign in
Genetic & Genomic MedicineAnnals of Clinical and Translational Neurology
Peer-reviewed journal article

Age-Related Characteristics of SYT1-Associated Neurodevelopmental Disorder

Sam G. NorwitziD, Josefine EckiD, Joel S. WinstoniD, Kate BakeriD

Abstract

ObjectivesWe describe the clinical manifestations and developmental abilities of individuals with SYT1-associated neurodevelopmental disorder (Baker-Gordon syndrome) from infancy to adulthood. We further describe the neuroradiological and electrophysiological characteristics of the condition at different ages, and explore the associations between these characteristics and clinical symptoms. MethodsParticipants were recruited to the UK-based Brain and Behavior in Neurodevelopmental Disorders of Genetic Origin project. Caregivers completed a medical history questionnaire and a battery of standardized neurodevelopmental measures. MRI and EEG records were obtained with consent from treating clinicians. Age-related clinical manifestations and neuroimaging records were systematically analyzed. Accuracy testing was used to explore brain-symptom associations. ResultsThis study describes 39 individuals with 29 distinct de novo SYT1 missense variants, including 11 novel variants. Qualitative age-related clinical trends included the resolution of hypotonia and worsening of movement disorders, sleep difficulties, and self-injurious behaviors. Social-communicative impairments were prominent, with evidence of progression with age. MRI abnormalities were identified in 48% of individuals, while EEG abnormalities were present in 92%. Epileptiform activity frequently co-occurred with movement disorders, while irregular sleep EEG coincided with sleep difficulties and respiratory problems. InterpretationThis study characterizes the broad spectrum and age-related progression of clinical symptoms and brain-related findings in individuals with SYT1-associated neurodevelopmental disorder. Further research is needed to understand factors contributing to within-individual change, and to develop targeted interventions aimed at improving outcomes and quality of life for affected individuals and their families.

02 /Specification & Classification

Click any tag to browse matching papers
Citations
2
FWCI
1.17
Field percentile
top 20%

Reproducibility ledger

Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.

Sign in to file a reproducibility report.

Similarity Map
SelectedSame fieldCross-field
THISMelland '22Granadillo '26Fenton '23Weerts '21Guzman '25Creson '19
74% semantic matchGenetic & Genomic Medicine
Holly Melland, Fabian Bumbak, Anna Kolesnik+23 more·Genetics in Medicine·Jan 28, 2022· 46 citations